Vertex Average Equity vs Earnings before Tax Analysis

VRTX Stock  USD 417.51  0.19  0.05%   
Trend analysis of Vertex Pharmaceuticals balance sheet accounts such as Total Assets of 23.9 B, Short Long Term Debt Total of 848.8 M, Other Current Liabilities of 3.1 B or Total Current Liabilities of 3.7 B provides information on Vertex Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Vertex Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Vertex Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.

About Vertex Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Vertex Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Vertex Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Vertex Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Vertex currently owns. An asset can also be divided into two categories, current and non-current.

Vertex Pharmaceuticals Balance Sheet Chart

Vertex Pharmaceuticals Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Vertex Pharmaceuticals uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Vertex Pharmaceuticals' Cash And Short Term Investments are fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 23.9 B in 2024, despite the fact that Net Debt is likely to grow to (9.1 B).

Total Assets

Total assets refers to the total amount of Vertex Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vertex Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Vertex Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Vertex Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Vertex Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vertex Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.At this time, Vertex Pharmaceuticals' Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 798.2 M in 2024, whereas Discontinued Operations is likely to drop (861.8 K) in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit6.7B7.9B8.6B9.0B
Total Revenue7.6B8.9B9.8B10.3B

Vertex Pharmaceuticals fundamental ratios Correlations

0.370.960.981.00.88-0.980.940.990.990.890.990.210.580.450.590.991.0-0.060.980.940.990.360.370.860.04
0.370.310.350.340.64-0.250.130.320.410.20.340.60.80.080.70.490.350.30.440.430.320.70.70.240.65
0.960.310.990.960.81-0.920.940.930.960.820.940.110.470.540.480.940.95-0.160.950.890.940.280.290.770.04
0.980.350.990.980.84-0.940.940.950.980.840.960.170.510.570.540.970.97-0.090.970.910.970.330.340.820.03
1.00.340.960.980.88-0.980.950.990.990.890.990.180.550.440.570.981.0-0.080.970.940.990.340.350.870.01
0.880.640.810.840.88-0.830.720.860.880.760.880.460.790.20.80.910.88-0.070.860.910.860.610.610.750.26
-0.98-0.25-0.92-0.94-0.98-0.83-0.94-1.0-0.94-0.96-0.99-0.2-0.55-0.38-0.54-0.96-0.990.06-0.95-0.94-0.99-0.33-0.34-0.840.0
0.940.130.940.940.950.72-0.940.940.930.840.93-0.10.340.470.290.890.94-0.120.930.880.930.060.070.79-0.14
0.990.320.930.950.990.86-1.00.940.960.951.00.210.580.390.570.971.0-0.050.960.950.990.350.360.840.02
0.990.410.960.980.990.88-0.940.930.960.830.960.190.540.490.590.980.97-0.060.960.910.970.360.370.880.04
0.890.20.820.840.890.76-0.960.840.950.830.940.270.580.250.540.880.92-0.040.860.90.940.350.360.750.03
0.990.340.940.960.990.88-0.990.931.00.960.940.230.60.40.590.981.0-0.070.970.950.990.370.380.850.04
0.210.60.110.170.180.46-0.2-0.10.210.190.270.230.65-0.010.820.30.220.180.20.270.230.970.970.230.6
0.580.80.470.510.550.79-0.550.340.580.540.580.60.65-0.110.790.670.590.10.610.660.570.720.730.390.53
0.450.080.540.570.440.2-0.380.470.390.490.250.4-0.01-0.110.130.460.430.270.470.290.430.10.10.33-0.2
0.590.70.480.540.570.8-0.540.290.570.590.540.590.820.790.130.660.580.070.550.580.590.870.880.590.41
0.990.490.940.970.980.91-0.960.890.970.980.880.980.30.670.460.660.990.010.980.940.980.460.470.830.12
1.00.350.950.971.00.88-0.990.941.00.970.921.00.220.590.430.580.99-0.060.980.950.990.360.370.850.03
-0.060.3-0.16-0.09-0.08-0.070.06-0.12-0.05-0.06-0.04-0.070.180.10.270.070.01-0.06-0.02-0.04-0.040.180.18-0.18-0.15
0.980.440.950.970.970.86-0.950.930.960.960.860.970.20.610.470.550.980.98-0.020.940.960.370.380.810.1
0.940.430.890.910.940.91-0.940.880.950.910.90.950.270.660.290.580.940.95-0.040.940.950.40.410.780.11
0.990.320.940.970.990.86-0.990.930.990.970.940.990.230.570.430.590.980.99-0.040.960.950.360.370.860.02
0.360.70.280.330.340.61-0.330.060.350.360.350.370.970.720.10.870.460.360.180.370.40.361.00.340.61
0.370.70.290.340.350.61-0.340.070.360.370.360.380.970.730.10.880.470.370.180.380.410.371.00.350.6
0.860.240.770.820.870.75-0.840.790.840.880.750.850.230.390.330.590.830.85-0.180.810.780.860.340.350.01
0.040.650.040.030.010.260.0-0.140.020.040.030.040.60.53-0.20.410.120.03-0.150.10.110.020.610.60.01
Click cells to compare fundamentals

Vertex Pharmaceuticals Account Relationship Matchups

Vertex Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets8.3B11.8B13.4B18.2B22.7B23.9B
Short Long Term Debt Total577.4M581.5M556.7M561M808.4M848.8M
Other Current Liab1.0B1.2B1.5B1.9B2.9B3.1B
Total Current Liabilities1.2B1.6B1.9B2.4B3.5B3.7B
Total Stockholder Equity6.1B8.7B10.1B13.9B17.6B18.5B
Property Plant And Equipment Net745.1M958.5M1.1B1.1B1.5B1.5B
Net Debt(2.5B)(5.4B)(6.2B)(9.9B)(9.6B)(9.1B)
Retained Earnings(1.9B)858.7M3.2B6.5B10.1B10.6B
Cash3.1B6.0B6.8B10.5B10.4B10.9B
Non Current Assets Total3.7B3.9B4.4B5.5B8.6B9.0B
Non Currrent Assets Other326.9M662.5M901.1M1.3B796.7M836.5M
Cash And Short Term Investments3.8B6.7B7.5B10.8B11.2B11.8B
Common Stock Shares Outstanding260.7M263.4M259.9M259.1M260.5M153.1M
Liabilities And Stockholders Equity8.3B11.8B13.4B18.2B22.7B23.9B
Non Current Liabilities Total1.0B1.5B1.5B1.8B1.6B1.7B
Other Current Assets213.5M308.4M187.2M74.4M620.5M651.5M
Other Stockholder Equity7.9B7.9B6.9B7.4B7.4B7.8B
Total Liab2.2B3.1B3.3B4.2B5.1B5.4B
Total Current Assets4.6B7.8B9.0B12.7B14.1B14.9B
Short Term Debt30.3M42.4M46.9M89.4M83.7M51.0M
Accounts Payable87.6M155.1M195M303.9M364.9M383.1M
Property Plant And Equipment Gross745.1M958.5M2.3B2.5B2.6B2.8B
Accumulated Other Comprehensive Income(2.0M)(68.5M)15.9M800K(14.3M)(13.6M)
Net Receivables633.5M885.4M1.1B1.4B1.6B1.6B
Common Stock Total Equity2.6M2.6M2.5M2.6M3.0M1.9M
Common Stock2.6M2.6M2.5M2.6M3.0M2.0M
Other Assets1.2B587.0M986.9M1.4B1.6B1.7B
Short Term Investments699.0M670.7M729.9M274.5M849.2M579.6M
Property Plant Equipment833.3M958.5M1.1B1.5B1.7B1.8B
Other Liab275.5M923.4M902.2M685.8M788.7M828.1M
Current Deferred Revenue62.3M191.5M171.7M159.6M170.3M118.8M
Inventory167.5M280.8M353.1M460.6M738.8M775.7M
Net Tangible Assets4.7B7.3B8.7B12.2B14.1B14.8B
Retained Earnings Total Equity(1.9B)858.7M3.2B6.5B7.5B7.9B
Long Term Debt Total583.9M581.6M538.6M539.0M619.9M632.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.181
Earnings Share
13.89
Revenue Per Share
38.297
Quarterly Revenue Growth
0.093
Return On Assets
0.1317
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.